Home/Filings/4/0001623919-16-000037
4//SEC Filing

EndoChoice Holdings, Inc. 4

Accession 0001623919-16-000037

CIK 0001623919operating

Filed

Mar 10, 7:00 PM ET

Accepted

Mar 11, 4:35 PM ET

Size

8.2 KB

Accession

0001623919-16-000037

Insider Transaction Report

Form 4
Period: 2016-03-09
Transactions
  • Purchase

    Common stock, par value $0.001 per share

    2016-03-10$4.68/sh+83,700$391,7161,998,759 total(indirect: By LLC)
  • Purchase

    Common stock, par value $0.001 per share

    2016-03-09$4.62/sh+144,000$665,2801,915,059 total(indirect: By LLC)
Holdings
  • Common stock, par value $0.001 per share

    5,625
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging, inclusively, from $4.545 to $4.66 per share on purchases reported for March 9, 2016, and from $4.60 to $.755 per share on purchases reported for March 10, 2016. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  • [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  • [F3]The reporting person is a Founder and Senior Managing Director of Envest Holdings LLC and as a result may be deemed to beneficially own the shares owned by Envest Holdings or related entities.

Issuer

EndoChoice Holdings, Inc.

CIK 0001623919

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001623919

Filing Metadata

Form type
4
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 4:35 PM ET
Size
8.2 KB